These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21129047)

  • 1. The metabolic syndrome: time to get off the merry-go-round?
    Reaven GM
    J Intern Med; 2011 Feb; 269(2):127-36. PubMed ID: 21129047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation.
    Saely CH; Rein P; Drexel H
    Horm Metab Res; 2007 Sep; 39(9):642-50. PubMed ID: 17846971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in Cushing's syndrome.
    Chanson P; Salenave S
    Neuroendocrinology; 2010; 92 Suppl 1():96-101. PubMed ID: 20829627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate?
    Ma X; Zhu S
    Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome.
    Reaven P
    J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
    Billups KL; Miner MM; Wierzbicki AS; Jackson G
    Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM
    Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
    Stern MP; Williams K; Hunt KJ
    Atheroscler Suppl; 2005 May; 6(2):3-6. PubMed ID: 15823490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS; Lip GY; Beevers DG; Blann AD
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and cardiovascular risk: implications for clinical practice.
    Eddy DM; Schlessinger L; Heikes K
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S5-10. PubMed ID: 18469838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why metabolic syndrome criteria have not made prime time: a view from the clinic.
    Sattar N
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S30-4. PubMed ID: 18469837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
    Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
    Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
    J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
    Song SH; Hardisty CA
    QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.